![](/images/general/no_picture/200_user.png)
Rury L Grisham
Examiner (ID: 4728)
Most Active Art Unit | 2672 |
Art Unit(s) | 2625, 2672 |
Total Applications | 220 |
Issued Applications | 194 |
Pending Applications | 0 |
Abandoned Applications | 26 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 16839801
[patent_doc_number] => 20210147813
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => DRUG SCREENING PLATFORM USING BIOMATERIAL SCAFFOLDS
[patent_app_type] => utility
[patent_app_number] => 17/045308
[patent_app_country] => US
[patent_app_date] => 2019-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17282
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17045308
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/045308 | DRUG SCREENING PLATFORM USING BIOMATERIAL SCAFFOLDS | Apr 2, 2019 | Pending |
Array
(
[id] => 17004526
[patent_doc_number] => 20210235687
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => CRYOPRESERVATION SOLUTION AND CRYOPRESERVATION METHOD
[patent_app_type] => utility
[patent_app_number] => 17/050722
[patent_app_country] => US
[patent_app_date] => 2019-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5548
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17050722
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/050722 | CRYOPRESERVATION SOLUTION AND CRYOPRESERVATION METHOD | Apr 1, 2019 | Pending |
Array
(
[id] => 16916294
[patent_doc_number] => 20210189386
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => NUCLEIC ACID CONSTRUCT, MEDICINAL COMPOSITION, ANTICANCER AGENT, ANTIVIRAL AGENT AND ANTIBACTERIAL AGENT
[patent_app_type] => utility
[patent_app_number] => 17/043138
[patent_app_country] => US
[patent_app_date] => 2019-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5363
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17043138
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/043138 | NUCLEIC ACID CONSTRUCT, MEDICINAL COMPOSITION, ANTICANCER AGENT, ANTIVIRAL AGENT AND ANTIBACTERIAL AGENT | Mar 28, 2019 | Pending |
Array
(
[id] => 16598428
[patent_doc_number] => 20210024959
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => ENGINEERED IMMUNE EFFECTOR CELLS AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/040951
[patent_app_country] => US
[patent_app_date] => 2019-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43893
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17040951
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/040951 | ENGINEERED IMMUNE EFFECTOR CELLS AND USE THEREOF | Mar 27, 2019 | Pending |
Array
(
[id] => 16541042
[patent_doc_number] => 20200407455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => GENETICALLY MODIFIED CELLS AND METHOD FOR PRODUCING SAME
[patent_app_type] => utility
[patent_app_number] => 16/980961
[patent_app_country] => US
[patent_app_date] => 2019-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14981
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16980961
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/980961 | GENETICALLY MODIFIED CELLS AND METHOD FOR PRODUCING SAME | Mar 14, 2019 | Pending |
Array
(
[id] => 16822546
[patent_doc_number] => 20210137839
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => COMPOSITIONS AND METHODS FOR MEMBRANE PROTEIN DELIVERY
[patent_app_type] => utility
[patent_app_number] => 16/970216
[patent_app_country] => US
[patent_app_date] => 2019-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 113971
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16970216
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/970216 | COMPOSITIONS AND METHODS FOR MEMBRANE PROTEIN DELIVERY | Feb 14, 2019 | Pending |
Array
(
[id] => 16613945
[patent_doc_number] => 20210032598
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => ACTIVATION-INDUCED TISSUE-EFFECTOR CELLS SUITABLE FOR CELL THERAPY AND EXTRACELLUAR VESICLES DERIVED THEREFROM
[patent_app_type] => utility
[patent_app_number] => 16/965835
[patent_app_country] => US
[patent_app_date] => 2019-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7192
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16965835
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/965835 | ACTIVATION-INDUCED TISSUE-EFFECTOR CELLS SUITABLE FOR CELL THERAPY AND EXTRACELLUAR VESICLES DERIVED THEREFROM | Jan 28, 2019 | Pending |
Array
(
[id] => 16506418
[patent_doc_number] => 20200385674
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-10
[patent_title] => EFFICIENT DERIVATION OF STABLE PLURIPOTENT BOVINE EMBRYONIC STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 16/960812
[patent_app_country] => US
[patent_app_date] => 2019-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16746
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16960812
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/960812 | EFFICIENT DERIVATION OF STABLE PLURIPOTENT BOVINE EMBRYONIC STEM CELLS | Jan 10, 2019 | Pending |
Array
(
[id] => 17082386
[patent_doc_number] => 20210277392
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => CHEMICALLY-MODIFIED GUIDE RNAS TO IMPROVE CRISPR-CAS PROTEIN SPECIFICITY
[patent_app_type] => utility
[patent_app_number] => 16/760868
[patent_app_country] => US
[patent_app_date] => 2018-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20056
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16760868
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/760868 | CHEMICALLY-MODIFIED GUIDE RNAS TO IMPROVE CRISPR-CAS PROTEIN SPECIFICITY | Nov 1, 2018 | Pending |
Array
(
[id] => 16514189
[patent_doc_number] => 20200393447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => BIOSENSORS FOR MEASURING CELL SIGNALING IN STRESSED AND HEALTHY CELLS
[patent_app_type] => utility
[patent_app_number] => 16/629485
[patent_app_country] => US
[patent_app_date] => 2018-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13785
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16629485
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/629485 | BIOSENSORS FOR MEASURING CELL SIGNALING IN STRESSED AND HEALTHY CELLS | Jul 5, 2018 | Abandoned |
Array
(
[id] => 18537786
[patent_doc_number] => 20230242886
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => METHOD FOR IN VITRO REPROGRAMMING OF FIBROBLASTS INTO SERTOLI CELLS AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/257221
[patent_app_country] => US
[patent_app_date] => 2018-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9949
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17257221
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/257221 | METHOD FOR IN VITRO REPROGRAMMING OF FIBROBLASTS INTO SERTOLI CELLS AND APPLICATION THEREOF | Jul 2, 2018 | Pending |
Array
(
[id] => 16112297
[patent_doc_number] => 20200208171
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => UNIVERSAL SELF-REGULATING MAMMALIAN CELL LINE PLATFORM FOR THE PRODUCTION OF BIOLOGICS
[patent_app_type] => utility
[patent_app_number] => 16/622509
[patent_app_country] => US
[patent_app_date] => 2018-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35918
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16622509
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/622509 | UNIVERSAL SELF-REGULATING MAMMALIAN CELL LINE PLATFORM FOR THE PRODUCTION OF BIOLOGICS | Jun 14, 2018 | Pending |
Array
(
[id] => 15708815
[patent_doc_number] => 20200101173
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-02
[patent_title] => Genome Editing System For Repeat Expansion Mutation
[patent_app_type] => utility
[patent_app_number] => 16/622739
[patent_app_country] => US
[patent_app_date] => 2018-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45923
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16622739
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/622739 | Genome Editing System For Repeat Expansion Mutation | Jun 13, 2018 | Pending |
Array
(
[id] => 15711191
[patent_doc_number] => 20200102361
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-02
[patent_title] => VIRAL EXPRESSION CONSTRUCT COMPRISING A FIBROBLAST GROWTH FACTOR 21 (FGF21) CODING SEQUENCE
[patent_app_type] => utility
[patent_app_number] => 16/615854
[patent_app_country] => US
[patent_app_date] => 2018-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34003
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16615854
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/615854 | VIRAL EXPRESSION CONSTRUCT COMPRISING A FIBROBLAST GROWTH FACTOR 21 (FGF21) CODING SEQUENCE | May 23, 2018 | Abandoned |
Array
(
[id] => 15988743
[patent_doc_number] => 20200170242
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-04
[patent_title] => CELL CRYOPRESERVATION FORMULATION AND CELL RECOVERY METHOD
[patent_app_type] => utility
[patent_app_number] => 16/616216
[patent_app_country] => US
[patent_app_date] => 2018-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2659
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16616216
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/616216 | CELL CRYOPRESERVATION FORMULATION AND CELL RECOVERY METHOD | May 23, 2018 | Pending |
Array
(
[id] => 13778749
[patent_doc_number] => 20190002913
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-03
[patent_title] => PROMOTERS, EXPRESSION CASSETTES, VECTORS, KITS, AND METHODS FOR THE TREATMENT OF ACHROMATOPSIA AND OTHER DISEASES
[patent_app_type] => utility
[patent_app_number] => 15/960048
[patent_app_country] => US
[patent_app_date] => 2018-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11961
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15960048
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/960048 | PROMOTERS, EXPRESSION CASSETTES, VECTORS, KITS, AND METHODS FOR THE TREATMENT OF ACHROMATOPSIA AND OTHER DISEASES | Apr 22, 2018 | Pending |
Array
(
[id] => 16779363
[patent_doc_number] => 20210116441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => New Uses Of Mammalian Muscle-Derived Stem Cells
[patent_app_type] => utility
[patent_app_number] => 16/604785
[patent_app_country] => US
[patent_app_date] => 2018-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4379
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16604785
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/604785 | New Uses Of Mammalian Muscle-Derived Stem Cells | Apr 8, 2018 | Pending |
Array
(
[id] => 15832411
[patent_doc_number] => 20200131487
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-30
[patent_title] => COMPOSITION CONTAINING C2CL ENDONUCLEASE FOR DIELECTRIC CALIBRATION AND METHOD FOR DIELECTRIC CALIBRATION USING SAME
[patent_app_type] => utility
[patent_app_number] => 16/491208
[patent_app_country] => US
[patent_app_date] => 2018-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4831
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16491208
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/491208 | COMPOSITION CONTAINING C2CL ENDONUCLEASE FOR DIELECTRIC CALIBRATION AND METHOD FOR DIELECTRIC CALIBRATION USING SAME | Mar 5, 2018 | Abandoned |
Array
(
[id] => 18932497
[patent_doc_number] => 11884905
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-30
[patent_title] => Fluidic chip for cell culture use, culture vessel, and culture method
[patent_app_type] => utility
[patent_app_number] => 16/484506
[patent_app_country] => US
[patent_app_date] => 2018-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 17
[patent_no_of_words] => 12594
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16484506
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/484506 | Fluidic chip for cell culture use, culture vessel, and culture method | Jan 17, 2018 | Issued |